Meiling Ji
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 19
- Colorectal Cancer Treatments and Studies 8
- Colorectal Cancer Surgical Treatments 3
-
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 3
- Co-authors
- Guodong He (22 shared papers)Jianmin Xu (20 shared papers)Ye Wei (24 shared papers)Wenju Chang (23 shared papers)Dexiang Zhu (24 shared papers)Li Ren (19 shared papers)Qingyang Feng (20 shared papers)Liangliang Yang (5 shared papers)
- Journals
- Cancer Management and Research (3 papers)Journal of Clinical Oncology (3 papers)Frontiers in Oncology (2 papers)Journal of Translational Medicine (2 papers)OncoTargets and Therapy (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Meiling Ji
50 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 105
- Cancer Research 286
- Oncology 249
- Immunology 171
- Molecular Biology 475
- Pulmonary and Respiratory Medicine 171
Countries citing papers authored by Meiling Ji
This map shows the geographic impact of Meiling Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Ji more than expected).
Fields of papers citing papers by Meiling Ji
This network shows the impact of papers produced by Meiling Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Ji. The network helps show where Meiling Ji may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiling Ji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 137 | |
| 2 | 2019 | 109 | |
| 3 | 2016 | 99 | |
| 4 | 2018 | 88 | |
| 5 | 2020 | 63 | |
| 6 | 2018 | 60 | |
| 7 | 2016 | 47 | |
| 8 | 2022 | 47 | |
| 9 | 2023 | 44 | |
| 10 | 2016 | 34 | |
| 11 | 2022 | 28 | |
| 12 | 2016 | 27 | |
| 13 | 2018 | 26 | |
| 14 | 2017 | 21 | |
| 15 | 2018 | 20 | |
| 16 | 2019 | 20 | |
| 17 | 2022 | 19 | |
| 18 | CCR7 high expression leads to cetuximab resistance by cross-talking with EGFR pathway in PI3K/AKT signals in colorectal cancer. | 2019 | 19 |
| 19 | 2016 | 18 | |
| 20 | 2019 | 18 |
About Meiling Ji
Meiling Ji is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 51 papers that have together received 1.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (8 papers), Ferroptosis and cancer prognosis (5 papers), RNA modifications and cancer (5 papers), Immune cells in cancer (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Plant Molecular Biology Research (3 papers), Epigenetics and DNA Methylation (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). The work is most often cited by research in Cancer Research (286 citations), Oncology (249 citations), Immunology (171 citations), Molecular Biology (475 citations) and Pulmonary and Respiratory Medicine (171 citations). Meiling Ji has collaborated with scholars based in China, United States and France. Frequent co-authors include Guodong He, Jianmin Xu, Ye Wei, Wenju Chang, Dexiang Zhu, Li Ren, Qingyang Feng, Liangliang Yang, Wentao Tang and Yihao Mao. Their work appears in journals such as Cancer Management and Research, Journal of Clinical Oncology, Frontiers in Oncology, Journal of Translational Medicine and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.